HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 494 filers reported holding HORIZON THERAPEUTICS PUB L in Q4 2020. The put-call ratio across all filers is 0.36 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,909 | -0.4% | 77 | -11.5% | 0.00% | 0.0% |
| Q2 2023 | $8,949 | -5.8% | 87 | 0.0% | 0.00% | -33.3% |
| Q1 2023 | $9,496 | -20.5% | 87 | -17.1% | 0.00% | 0.0% |
| Q4 2022 | $11,949 | +139.0% | 105 | +20.7% | 0.00% | +50.0% |
| Q3 2022 | $5,000 | -77.3% | 87 | -68.0% | 0.00% | -71.4% |
| Q2 2022 | $22,000 | -48.8% | 272 | -34.1% | 0.01% | -36.4% |
| Q1 2022 | $43,000 | -17.3% | 413 | -14.7% | 0.01% | -15.4% |
| Q4 2021 | $52,000 | -13.3% | 484 | -10.7% | 0.01% | -27.8% |
| Q3 2021 | $60,000 | +20.0% | 542 | +2.1% | 0.02% | +28.6% |
| Q2 2021 | $50,000 | +4.2% | 531 | +0.6% | 0.01% | 0.0% |
| Q1 2021 | $48,000 | +23.1% | 528 | 0.0% | 0.01% | +16.7% |
| Q4 2020 | $39,000 | -4.9% | 528 | -0.6% | 0.01% | -14.3% |
| Q3 2020 | $41,000 | +41.4% | 531 | +3.5% | 0.01% | +55.6% |
| Q2 2020 | $29,000 | +107.1% | 513 | +9.6% | 0.01% | +80.0% |
| Q1 2020 | $14,000 | 0.0% | 468 | +18.2% | 0.01% | +25.0% |
| Q4 2019 | $14,000 | +1300.0% | 396 | +970.3% | 0.00% | – |
| Q3 2019 | $1,000 | – | 37 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 544,835 | $57,322,000 | 30.98% |
| Paulson & Co. | 5,614,000 | $590,649,000 | 18.18% |
| Avoro Capital Advisors LLC | 6,500,000 | $683,865,000 | 12.48% |
| 1492 Capital Management LLC | 121,840 | $12,819,000 | 6.80% |
| Iron Triangle Partners LP | 503,744 | $52,999,000 | 6.30% |
| Tri Locum Partners LP | 132,332 | $13,923,000 | 5.44% |
| HealthCor Management, L.P. | 710,110 | $74,711,000 | 4.98% |
| Eversept Partners, LP | 609,939 | $64,171,682 | 4.93% |
| Bain Capital Public Equity Management II, LLC | 1,286,371 | $135,339,000 | 4.33% |
| PFM Health Sciences, LP | 1,091,840 | $114,872,000 | 4.30% |